- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of High-Density Lipoprotein Cholesterol in 2022
Authors
Keywords
-
Journal
Current Atherosclerosis Reports
Volume 24, Issue 5, Pages 365-377
Publisher
Springer Science and Business Media LLC
Online
2022-03-11
DOI
10.1007/s11883-022-01012-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Very High High-Density Lipoprotein Cholesterol Levels and Cardiovascular Mortality
- (2022) Chang Liu et al. AMERICAN JOURNAL OF CARDIOLOGY
- The Fatty Acid Lipid Metabolism Nexus in COVID-19
- (2021) Jerome E. Tanner et al. Viruses-Basel
- Administration of the High-Density Lipoprotein Mimetic CER-001 for Inherited Lecithin–Cholesterol Acyltransferase Deficiency
- (2021) Stanislas Faguer et al. ANNALS OF INTERNAL MEDICINE
- The effect of transgender hormonal treatment on high density lipoprotein cholesterol efflux capacity
- (2021) Daan M. van Velzen et al. ATHEROSCLEROSIS
- Elevated apolipoprotein A1 and HDL cholesterol associated with age-related macular degeneration: two population cohorts
- (2021) Liv Tybjærg Nordestgaard et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- HDL Particle Subspecies and Their Association With Incident Type 2 Diabetes: The PREVEND Study
- (2021) Sara Sokooti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cardiovascular risk and testosterone – from subclinical atherosclerosis to lipoprotein function to heart failure
- (2021) Baris Gencer et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases
- (2021) Anna Wolska et al. Cells
- The Difference Between High Density Lipoprotein Subfractions and Subspecies: an Evolving Model in Cardiovascular Disease and Diabetes
- (2021) W. Sean Davidson et al. Current Atherosclerosis Reports
- HDL Containing Apolipoprotein C-III is Associated with Insulin Sensitivity: a Multi-Center Cohort Study
- (2021) Rain Yamamoto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Genome-Wide Association Study Identifies a Functional SIDT2 Variant Associated With HDL-C (High-Density Lipoprotein Cholesterol) Levels and Premature Coronary Artery Disease
- (2021) Paola León-Mimila et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Niacin Increases Atherogenic Proteins in High-Density Lipoprotein of Statin-Treated Subjects
- (2021) Graziella E. Ronsein et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research
- (2021) Anand Rohatgi et al. CIRCULATION
- Molecular Patterns of Extreme and Persistent Cholesterol Efflux Capacity
- (2021) Ayea El-Ghazali et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- HDL cholesterol concentrations and risk of atherosclerotic cardiovascular disease – Insights from randomized clinical trials and human genetics
- (2021) Emilie Westerlin Kjeldsen et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- High-density lipoproteins: A promising tool against cancer
- (2021) Alice Ossoli et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- HDL proteome remodeling associates with COVID-19 severity
- (2021) Douglas Ricardo Souza Junior et al. Journal of Clinical Lipidology
- The HDL mimetic CER‐001 remodels plasma lipoproteins and reduces kidney lipid deposits in inherited lecithin:cholesterol acyltransferase deficiency
- (2021) Chiara Pavanello et al. JOURNAL OF INTERNAL MEDICINE
- Reproducible Determination of High-Density Lipoprotein Proteotypes
- (2021) Sandra Goetze et al. JOURNAL OF PROTEOME RESEARCH
- Lipoprotein(a): Knowns, unknowns and uncertainties
- (2021) Massimiliano Ruscica et al. PHARMACOLOGICAL RESEARCH
- Long-term Benefits and Harms Associated With Genetic Cholesteryl Ester Transfer Protein Deficiency in the General Population
- (2021) Liv Tybjærg Nordestgaard et al. JAMA Cardiology
- HDL in COVID-19 Patients: Evidence from an Italian Cross-Sectional Study
- (2021) Bianca Papotti et al. Journal of Clinical Medicine
- Apolipoprotein A-I concentrations and risk of coronary artery disease: A Mendelian randomization study
- (2020) Minna K. Karjalainen et al. ATHEROSCLEROSIS
- A PPARA Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD Lipid
- (2020) Mario Luca Morieri et al. DIABETES
- HDL inhibits endoplasmic reticulum stress-induced apoptosis of pancreatic β-cells in vitro by activation of Smoothened
- (2020) Mustafa Yalcinkaya et al. JOURNAL OF LIPID RESEARCH
- Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis
- (2020) Hiurma Sánchez-Pérez et al. RHEUMATOLOGY
- Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib
- (2020) Jean-Claude Tardif et al. AMERICAN HEART JOURNAL
- LDL-Cholesterol Reduction by ANGPTL3 Inhibition in Mice Is Dependent on Endothelial Lipase
- (2020) Liya Wu et al. CIRCULATION RESEARCH
- Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia
- (2020) Daniel Gaudet et al. EUROPEAN HEART JOURNAL
- Lipid and Metabolic Syndrome Traits in Coronary Artery Disease: A Mendelian Randomization Study
- (2020) David G Thomas et al. JOURNAL OF LIPID RESEARCH
- Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein
- (2020) Christine Toelzer et al. SCIENCE
- Inhibition of Cholesteryl Ester Transfer Protein Preserves High-Density Lipoprotein Cholesterol and Improves Survival in Sepsis
- (2020) Mark Trinder et al. CIRCULATION
- HDL in Morbidity and Mortality: A 40+ Year Perspective
- (2020) Alan R Tall CLINICAL CHEMISTRY
- CER-001 ameliorates lipid profile and kidney disease in a mouse model of familial LCAT deficiency
- (2020) Alice Ossoli et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- High density lipoprotein function is reduced in patients affected by genetic or idiopathic hypogonadism
- (2019) Maria Pia Adorni et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- HDL (High-Density Lipoprotein) Cholesterol Efflux Capacity Is Associated With Incident Cardiovascular Disease in the General Population
- (2019) Sanam Ebtehaj et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Impact of ADCY9 Genotype on Response to Anacetrapib
- (2019) Jemma C. Hopewell et al. CIRCULATION
- HDL therapy today: from atherosclerosis, to stent compatibility to heart failure
- (2019) C.R. Sirtori et al. ANNALS OF MEDICINE
- High-density lipoprotein cholesterol efflux capacity is not associated with atherosclerosis and prevalence of cardiovascular outcome: The CODAM study
- (2019) Tatjana Josefs et al. Journal of Clinical Lipidology
- Scavenger receptor class B, type 1 facilitates cellular fatty acid uptake
- (2019) Wei Wang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Cholesterol membrane content has a ubiquitous evolutionary function in immune cell activation
- (2019) Fabrizia Bonacina et al. CURRENT OPINION IN LIPIDOLOGY
- Role of Lipoproteins in the Microenvironment of Hormone-Dependent Cancers
- (2019) Monica Gomaraschi TRENDS IN ENDOCRINOLOGY AND METABOLISM
- APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe −/− atherosclerotic mice
- (2018) Gabriele Romano et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Present therapeutic role of cholesteryl ester transfer protein inhibitors
- (2018) Nicola Ferri et al. PHARMACOLOGICAL RESEARCH
- High Density Lipoproteins Inhibit Oxidative Stress-Induced Prostate Cancer Cell Proliferation
- (2018) Massimiliano Ruscica et al. Scientific Reports
- ADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease
- (2018) Steven E. Nissen et al. JAMA Cardiology
- Translating Evidence of HDL and Plaque Regression
- (2018) Belinda A. Di Bartolo et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Successful treatment of established heart failure in mice with recombinant HDL (Milano)
- (2018) Joseph Pierre Aboumsallem et al. BRITISH JOURNAL OF PHARMACOLOGY
- Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
- (2018) Reza Fadaei et al. Scientific Reports
- Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial
- (2018) Stephen J. Nicholls et al. JAMA Cardiology
- Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial
- (2018) Stephen J. Nicholls et al. JAMA Cardiology
- Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
- (2018) Aruna D. Pradhan et al. AMERICAN HEART JOURNAL
- Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque
- (2018) Steven Shea et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Left main coronary wall thickness correlates with the carotid intima media thickness and may provide a new marker of cardiovascular risk
- (2018) Massimiliano Ruscica et al. European Journal of Preventive Cardiology
- High-Density Lipoprotein–Targeted Therapies—Not Dead Yet
- (2018) Alvaro Garcia-Ropero et al. JAMA Cardiology
- Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies
- (2017) Christian M. Madsen et al. EUROPEAN HEART JOURNAL
- PPAR-α agonists are still on the rise: an update on clinical and experimental findings
- (2017) Nicola Ferri et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
- (2017) A. Michael Lincoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes
- (2017) Marshall B. Elam et al. JAMA Cardiology
- Trials and Tribulations of CETP Inhibitors
- (2017) Alan R. Tall et al. CIRCULATION RESEARCH
- Evacetrapib alone or in combination with statins lowers lipoprotein(a) and total and small LDL particle concentrations in mildly hypercholesterolemic patients
- (2016) Stephen J. Nicholls et al. Journal of Clinical Lipidology
- Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism
- (2016) Ilenia Minicocci et al. JOURNAL OF LIPID RESEARCH
- Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes
- (2016) Jon White et al. JAMA Cardiology
- Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia
- (2015) Masatsune Ogura et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cholesterol-Overloaded HDL Particles Are Independently Associated With Progression of Carotid Atherosclerosis in a Cardiovascular Disease-Free Population
- (2015) Yue Qi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial
- (2015) G Kees Hovingh et al. LANCET
- Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study
- (2015) Danish Saleheen et al. Lancet Diabetes & Endocrinology
- HDL in innate and adaptive immunity
- (2014) A. L. Catapano et al. CARDIOVASCULAR RESEARCH
- Decreased Cholesterol Efflux Capacity and Atherogenic Lipid Profile in Young Women With PCOS
- (2014) Andrea Roe et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Coronary Heart Disease Risks Associated with High Levels of HDL Cholesterol
- (2014) John T. Wilkins et al. Journal of the American Heart Association
- High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy
- (2013) Samia Mora et al. CIRCULATION
- High-density lipoproteins: A consensus statement from the National Lipid Association
- (2013) Peter P. Toth et al. Journal of Clinical Lipidology
- HDL and Cardiovascular Risk
- (2012) Bernd Hewing et al. CIRCULATION RESEARCH
- High-density lipoprotein subclasses and their relationship to cardiovascular disease
- (2012) H. Robert Superko et al. Journal of Clinical Lipidology
- High-Density Lipoprotein Cholesterol and Particle Concentrations, Carotid Atherosclerosis, and Coronary Events
- (2012) Rachel H. Mackey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
- (2012) Benjamin F Voight et al. LANCET
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relation Between High-Density Lipoprotein Cholesterol and Survival to Age 85 Years in Men (from the VA Normative Aging Study)
- (2011) Catherine R. Rahilly-Tierney et al. AMERICAN JOURNAL OF CARDIOLOGY
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
- (2011) Amit V. Khera et al. NEW ENGLAND JOURNAL OF MEDICINE
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of High-Density Lipoproteins on Pancreatic β-Cell Insulin Secretion
- (2010) Michelle A. Fryirs et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Paraoxonase2 C311S polymorphism and low levels of HDL contribute to a higher mortality risk after acute myocardial infarction in elderly patients
- (2009) Francesca Marchegiani et al. MOLECULAR GENETICS AND METABOLISM
- Change in High-Density Lipoprotein Cholesterol and Incident Coronary Heart Disease in Apparently Healthy Male Physicians
- (2008) Catherine Rahilly-Tierney et al. AMERICAN JOURNAL OF CARDIOLOGY
- Low HDL Cholesterol Is a Risk Factor for Deficit and Decline in Memory in Midlife
- (2008) Archana Singh-Manoux et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Infusion of Reconstituted High-Density Lipoprotein Leads to Acute Changes in Human Atherosclerotic Plaque
- (2008) James A. Shaw et al. CIRCULATION RESEARCH
- Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
- (2008) R. Scott et al. DIABETES CARE
- High-density lipoprotein cholesterol, C-reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography
- (2008) H. F. Alber et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients
- (2008) LeAnne T. Bloedon et al. JOURNAL OF LIPID RESEARCH
- High-Density Lipoprotein Cholesterol, High-Density Lipoprotein Particle Size, and Apolipoprotein A-I: Significance for Cardiovascular Risk
- (2008) Wim A. van der Steeg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clinical Significance of High-Density Lipoprotein Cholesterol in Patients With Low Low-Density Lipoprotein Cholesterol
- (2008) Emil M. deGoma et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started